Avidity Biosciences
Avidity Biosciences, Inc. is a biotechnology company based in San Diego, California, specializing in RNA therapeutics. The company utilizes its proprietary Antibody Oligonucleotide Conjugates (AOCs™) platform to develop targeted therapies for rare diseases, with a particular focus on neuromuscular disorders. Avidity aims to revolutionize RNA therapeutics by combining the specificity of monoclonal antibodies with the precision of oligonucleotides, enabling effective treatment of previously untreatable conditions. Avidity's clinical-stage pipeline includes programs targeting Myotonic Dystrophy Type 1, Facioscapulohumeral Muscular Dystrophy, and Duchenne Muscular Dystrophy. The company is also exploring opportunities in precision cardiology and immunology. With a team of approximately 391 employees, Avidity is committed to innovation in the field of rare diseases, collaborating with healthcare providers and academic institutions to enhance patient outcomes.
Work at Avidity Biosciences in HR or recruiting? Claim this page
Headcount trend
Avidity Biosciences went from 274 employees in Oct 2024 to 395 in Sep 2026. Apr to Sep 2026: 9 people joined, 43 left.
Org structure
Headcount by department
H-1B sponsorship
The department split adds up all the years listed above. FY2026 alone: 2 filings.
Peer reviews
Worked with someone at Avidity Biosciences?
Anonymous peer reviews on OffTheRecord
Similar companies
Avidity Biosciences FAQ
How many employees does Avidity Biosciences have?
Avidity Biosciences has about 395 employees, up 1.3% over the 3 months to Sep 2026.
Does Avidity Biosciences sponsor H1B visas?
Yes. Avidity Biosciences filed 2 H1B (LCA) applications in FY2026, according to the latest U.S. Department of Labor disclosures. Most of them were for Engineering roles.
What is Avidity Biosciences's revenue per employee?
Avidity Biosciences makes about $23K in revenue per employee, based on $8.92M annual revenue and 395 employees.
Is Avidity Biosciences a public company?
Yes. Avidity Biosciences is publicly traded under the ticker RNA on NASDAQ.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.
